Case number: 7:23-bk-22415 - Endo Operations Limited - New York Southern Bankruptcy Court

Case Information
  • Case title

    Endo Operations Limited

  • Court

    New York Southern (nysbke)

  • Chapter

    11

  • Judge

    James L. Garrity Jr.

  • Filed

    05/31/2023

  • Last Filing

    07/17/2023

  • Asset

    Yes

  • Vol

    v

Docket Header
MEGA, MEGANY, JtAdm, CLMAGT



U.S. Bankruptcy Court
Southern District of New York (White Plains)
Bankruptcy Petition #: 23-22415-jlg

Assigned to: Judge James L. Garrity Jr.
Chapter 11
Voluntary
Asset


Date filed:  05/31/2023

Debtor

Endo Operations Limited

1400 Atwater Drive
Malvern, PA 19355
CHESTER-PA
Tax ID / EIN: 00-0000000
aka
Zoo Universal Pharmaceuticals III Limited

fka
Operand Pharmaceuticals III Limited


represented by
Lisa Laukitis

Skadden, Arps, Slate, Meagher & Flom LLP
One Manhattan West
New York, NY 10001-8602
212-735-3000
Fax : 212-735-2000
Email: lisa.laukitis@skadden.com

Paul D. Leake

Skadden, Arps, Slate, Meagher & Flom LLP
One Manhattan West
New York, NY 10001
212-735-3000
Fax : 212-735-2000
Email: paul.leake@skadden.com

Kyle J. Ortiz

Togut, Segal & Segal LLP
One Penn Plaza
Suite 3335
New York, NY 10119
212-594-5000
Fax : 212-967-4258
Email: kortiz@teamtogut.com

U.S. Trustee

United States Trustee

Office of the United States Trustee - NY
Alexander Hamilton Custom House
One Bowling Green, Room 534
New York, NY 10004-1408
(212) 510-0500

 
 
Claims and Noticing Agent

Kroll Restructuring Administration LLC Claims Agent

(Formerly Prime Clerk LLC)
55 East 52nd Street
17th Floor
www.kroll.com
New York, NY 10055
(212) 257-5450
 
 

Latest Dockets

Date Filed#Docket Text
07/17/2023
Pending Deadlines Terminated: All Schedules and Statements.
(Rodriguez, Willie) (Entered: 07/17/2023)
07/14/20239Statement of Financial Affairs - Non-Individual /Global Notes and Statement of Financial Affairs for Operand Pharmaceuticals III Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals III Limited. (Ortiz, Kyle) (Entered: 07/14/2023)
07/14/20238Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Global Notes, Summary and Schedules of Assets and Liabilities for Operand Pharmaceuticals III Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals III Limited. (Ortiz, Kyle) (Entered: 07/14/2023)
07/06/20237Order signed on 7/6/2023 Granting Motion To Extend Deadline to File Schedules or Provide Required Information:
Deadline: 7/14/2023
(Related Doc # 3) (Rodriguez, Willie) (Entered: 07/06/2023)
07/06/2023Deficiencies Set: Schedule A/B due 6/14/2023. Schedule D due 6/14/2023. Schedule E/F due 6/14/2023. Schedule G due 6/14/2023. Schedule H due 6/14/2023. Summary of Assets and Liabilities due 6/14/2023. Statement of Financial Affairs due 6/14/2023. Incomplete Filings due by 6/14/2023, (Porter, Minnie). (Entered: 07/06/2023)
06/30/20236Transcript regarding Hearing Held on 6/22/2023 at 11:09 AM RE: Motion to Extend Deadline to File Schedules or Provide Required Information.
Remote electronic access to the transcript is restricted until 9/28/2023.
The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: eScribers, LLC.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) 3). Notice of Intent to Request Redaction Deadline Due By 7/7/2023. Statement of Redaction Request Due By 7/21/2023. Redacted Transcript Submission Due By 7/31/2023. Transcript access will be restricted through 9/28/2023. (Ortiz, Carmen) (Entered: 06/30/2023)
06/20/20235Certificate of No Objection Pursuant to LR 9075-2 /Certificate of No Objection to Motion of the Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs for the Additional Debtors and Any Future Debtors Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals III Limited. (Ortiz, Kyle) (Entered: 06/20/2023)
06/16/20234Disclosure of Compensation of Attorney For Debtor (Rule 2016(b))- Form 2030 Filed by Lisa Laukitis on behalf of Operand Pharmaceuticals III Limited. (Laukitis, Lisa) (Entered: 06/16/2023)
06/08/2023Claims and Noticing Agent, Kroll Restructuring Administration LLC, added to the case. (Rodriguez, Willie). (Entered: 06/08/2023)
06/08/2023
Case Jointly Administrated with Case # 22-22549 per Order signed on 8/17/2023 in Case # 22-22549 Doc # 45.
(Rodriguez, Willie). (Entered: 06/08/2023)